ATE99943T1 - Psychotropische wirkstoffe enthaltende stabilisierte loesungen. - Google Patents

Psychotropische wirkstoffe enthaltende stabilisierte loesungen.

Info

Publication number
ATE99943T1
ATE99943T1 AT90203064T AT90203064T ATE99943T1 AT E99943 T1 ATE99943 T1 AT E99943T1 AT 90203064 T AT90203064 T AT 90203064T AT 90203064 T AT90203064 T AT 90203064T AT E99943 T1 ATE99943 T1 AT E99943T1
Authority
AT
Austria
Prior art keywords
stabilized
active ingredients
methionine
solutions containing
stabilized solutions
Prior art date
Application number
AT90203064T
Other languages
English (en)
Inventor
Den Oetelaar Petrus Johann Van
Maria Martina Francisc Mentink
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE99943T1 publication Critical patent/ATE99943T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
AT90203064T 1989-12-06 1990-11-20 Psychotropische wirkstoffe enthaltende stabilisierte loesungen. ATE99943T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89203092 1989-12-06
EP90203064A EP0431663B1 (de) 1989-12-06 1990-11-20 Psychotropische Wirkstoffe enthaltende stabilisierte Lösungen

Publications (1)

Publication Number Publication Date
ATE99943T1 true ATE99943T1 (de) 1994-01-15

Family

ID=8202518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90203064T ATE99943T1 (de) 1989-12-06 1990-11-20 Psychotropische wirkstoffe enthaltende stabilisierte loesungen.

Country Status (15)

Country Link
US (1) US5082864A (de)
EP (1) EP0431663B1 (de)
JP (1) JP2977912B2 (de)
KR (1) KR0185377B1 (de)
AT (1) ATE99943T1 (de)
AU (1) AU628768B2 (de)
CA (1) CA2030773C (de)
DE (1) DE69005992T2 (de)
DK (1) DK0431663T3 (de)
ES (1) ES2062310T3 (de)
FI (1) FI97689C (de)
IE (1) IE63985B1 (de)
NZ (1) NZ236332A (de)
PT (1) PT96096B (de)
ZA (1) ZA909568B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1591H (en) * 1992-10-09 1996-09-03 Fulcher; John Preparation of flavor-enhanced reduced calorie fried foods
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
EP0813873B1 (de) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmazeutische Zusammensetzungen mit Mirtazapin und einem oder mehreren selektiven Serotonin-Aufnahme Inhibitoren
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL123716A (en) * 1997-03-27 2001-03-19 Akzo Nobel Nv Therapeutic combinations of mirtazapine and an antipsychotic agent
WO1999051237A1 (en) * 1998-04-02 1999-10-14 Akzo Nobel N.V. Oral liquid antidepressant solution
US6211171B1 (en) 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
JP2004532190A (ja) * 2001-02-12 2004-10-21 アクゾ・ノベル・エヌ・ベー アポリポタンパク質ｅ４の遺伝子の遺伝子型決定により大うつ病の治療を改善するための方法
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
ATE388698T1 (de) 2003-04-29 2008-03-15 Orexigen Therapeutics Inc Zusammensetzungen zur beeinflussung des gewichtsverlusts
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2005070461A2 (en) * 2004-01-13 2005-08-04 Duke University Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
US20060058390A1 (en) * 2004-09-14 2006-03-16 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
PT2135603E (pt) 2005-11-22 2013-04-03 Orexigen Therapeutics Inc Composições e métodos para aumentar a sensibilidade à insulina
AU2007207606A1 (en) * 2006-01-17 2007-07-26 Regents Of The University Of Colorado Central administration of stable formulations of therapeutic agents for CNS conditions
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
JP2010509367A (ja) 2006-11-09 2010-03-25 オレキシジェン・セラピューティクス・インコーポレーテッド 積層製剤
KR20090090316A (ko) 2006-11-09 2009-08-25 오렉시젠 세러퓨틱스 인크. 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법
EP2167096A4 (de) * 2007-06-13 2010-07-14 Cypress Bioscience Inc Verbesserung der verträglichkeit von mirtazapin und eines zweiten wirkstoffes durch ihre kombinierte verwendung
JP2011521973A (ja) * 2008-05-30 2011-07-28 オレキシジェン・セラピューティクス・インコーポレーテッド 内臓脂肪の状態を処置するための方法
KR20120124423A (ko) 2010-01-11 2012-11-13 오렉시젠 세러퓨틱스 인크. 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
PT3730132T (pt) 2012-06-06 2022-08-16 Nalpropion Pharmaceuticals Llc Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular
KR101652081B1 (ko) 2014-12-30 2016-08-30 김인호 전극보일러 급탕시스템
EP3261645B1 (de) 2015-02-27 2021-04-28 Dechra Limited Anregung des appetits, verwaltung von gewichtsverlust und behandlung von anorexie bei hunden und katzen
KR20170001494A (ko) 2015-06-26 2017-01-04 김인호 전극보일러 전류제어시스템
CN108853042B (zh) * 2018-09-20 2021-03-26 北京哈三联科技有限责任公司 一种米氮平冻干口崩片及其制备方法和应用
GR1009883B (el) * 2019-06-07 2020-12-11 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν υδροχλωρικη νορτριπτυλινη

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
DE3247676A1 (de) * 1982-12-23 1984-06-28 A. Nattermann & Cie GmbH, 5000 Köln Galenische form fuer amitriptylinoxid und verfahren zur herstellung

Also Published As

Publication number Publication date
AU6779890A (en) 1991-06-13
ES2062310T3 (es) 1994-12-16
CA2030773A1 (en) 1991-06-07
US5082864A (en) 1992-01-21
CA2030773C (en) 2001-07-24
IE904226A1 (en) 1991-06-19
EP0431663B1 (de) 1994-01-12
ZA909568B (en) 1991-09-25
FI906008A0 (fi) 1990-12-05
DE69005992D1 (de) 1994-02-24
IE63985B1 (en) 1995-06-28
JP2977912B2 (ja) 1999-11-15
PT96096B (pt) 1998-02-27
KR910011250A (ko) 1991-08-07
DK0431663T3 (da) 1994-03-07
FI97689B (fi) 1996-10-31
EP0431663A1 (de) 1991-06-12
JPH05262651A (ja) 1993-10-12
KR0185377B1 (ko) 1999-05-01
FI97689C (fi) 1997-02-10
AU628768B2 (en) 1992-09-17
DE69005992T2 (de) 1994-05-05
NZ236332A (en) 1992-07-28
PT96096A (pt) 1991-09-30
FI906008A (fi) 1991-06-07

Similar Documents

Publication Publication Date Title
ATE99943T1 (de) Psychotropische wirkstoffe enthaltende stabilisierte loesungen.
DE69629209D1 (de) Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose
NO2002009I2 (no) Tiotropium
DE59407820D1 (de) Mischkapsel für Dentalmassen
ATE74499T1 (de) Eine waessrige phase enthaltende riechstoffzusammensetzung mit einer hohen riechstoffkonzentration.
DK0675717T3 (da) Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin
EE9500015A (et) Meetod pranoprofeeni stabiliseerimiseks ja pranoprofeeni stabiilne vedelpreparaat
DE50010978D1 (de) Kosmetische Stiftzubereitung
ATE318599T1 (de) Famotidin-injektionen
DE68905414T2 (de) 2-substituierte paraaminophenole und ihre verwendung fuer die faerbung von keratinischen fasern.
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
FI910112A (fi) Preparat foer lokalt bruk.
GB2000970A (en) Injectable chloramphenicol composition
ES2000033A6 (es) Composicion de bitionol sulfoxido porcedimiento para su fabricacion y metodo de utilizacion de aquella
SE7514294L (sv) 4,4'-bis-/2",4"-bis-(diisopropanolamino)-s-triazin-6"-ylamino/-stilben-2,2'-disulfonsyra, dess framstellning och dess anvendning som optiskt vithetsforhojande medel
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
ATE149360T1 (de) Zahnseide mit chemotherapeutischen wirkstoffen
DK0925785T3 (da) Stabiliseret farmaceutisk præparat indeholdende dopamin eller dobutamin
RO94553A (ro) Compozitie insecticida
KR927003055A (ko) 케토티펜 외용제제
ATE104966T1 (de) 9-(acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde mittel davon als aktiver wirkstoff.
NO890314D0 (no) Sv40 ekspresjonsvektor som inneholder hbxag som ekspresjonsmarkoer.
ES2017640B3 (es) Derivado de triazina, su preparacion y empleo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time